Prevalence, Diagnosis, and Treatment of Cardiac Tumors: A Narrative Review
Journal of Clinical Medicine · 13.05.2025 · 14 (10) · 3392
DOI: 10.3390/jcm14103392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.05.2025. Verfasst von Mohamed Rahouma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery Department, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 10065, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiac tumors, though rare, present significant diagnostic and therapeutic challenges due to their heterogeneous nature and anatomical complexity. This narrative review synthesizes current evidence on prevalence, diagnostic modalities, and management strategies for primary and metastatic cardiac tumors. Echocardiography, cardiac MRI, and CT remain cornerstone imaging tools for differentiating tumors from non-neoplastic masses, while advances in PET/CT and tissue characterization techniques refine staging and treatment planning. Surgical resection with clear margins (R0) is critical for resectable tumors, particularly benign myxomas, though malignant tumors like sarcomas require multimodal approaches combining surgery, radiotherapy, and systemic therapies. Emerging strategies such as heart autotransplantation and staged resections offer promise for complex cases, while oligometastatic disease management highlights the role of stereotactic radiotherapy and immunotherapy. Key challenges include standardizing resection margins, optimizing neoadjuvant therapies, and addressing high recurrence rates in malignancies. Future directions emphasize integrating AI-driven imaging analysis, molecular biomarkers, and genomic profiling to personalize therapies, alongside global registries to enhance data on rare tumors. Equitable access to advanced diagnostics and multidisciplinary collaboration are essential to improve outcomes. This review underscores the need for standardized guidelines, technological innovation, and patient-centered research to address gaps in cardiac oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Surgery Department, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY 10065, USA.
- Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
- Department of Cardiothoracic Surgery, Faculty of Medicine, Beni Suef University, Beni Suef 62511, Egypt.
- Department of Biology and Psychology, Stony Brook University, Stony Brook, NY 11794, USA.
- Cardiothoracic Surgery Department, NYU Langone Health, New York, NY 10016, USA.
- Cardiothoracic Surgery Department, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Mohamed Rahouma, Hosny Mohsen, Mahmoud Morsi, Magdy M El-Sayed Ahmed
Zitieren
APA
Rahouma, M., Mohsen, H., Morsi, M., Khairallah, S., Azab, L., Abdelhemid, M., Kumar, A., & El-Sayed Ahmed, M. M. (2025). Prevalence, Diagnosis, and Treatment of Cardiac Tumors: A Narrative Review. Journal of Clinical Medicine, 14(10), 3392. https://doi.org/10.3390/jcm14103392
Vancouver
Rahouma M, Mohsen H, Morsi M, Khairallah S, Azab L, Abdelhemid M, et al. Prevalence, Diagnosis, and Treatment of Cardiac Tumors: A Narrative Review. Journal of Clinical Medicine. 2025;14(10):3392. doi:10.3390/jcm14103392
BibTeX
@article{Rahouma2025,
author = {Rahouma, Mohamed and Mohsen, Hosny and Morsi, Mahmoud and Khairallah, Sherif and Azab, Lilian and Abdelhemid, Maya and Kumar, Akshay and El-Sayed Ahmed, Magdy M},
title = {Prevalence, Diagnosis, and Treatment of Cardiac Tumors: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {10},
pages = {3392},
doi = {10.3390/jcm14103392}
}
EUVIMED